| Boehringer Ingelheim reports positive linagliptin trial data - Zenopa |
|
|
ZenopaIn addition, linagliptin proved to demonstrate similar performance among patients with varying levels of mild and moderate renal impairment. ...Four Phase III Trials Confirm Benefits of BI's Oral, Once-Daily Type 2 ... Genetic Engineering NewsLinagliptin phase III data announced Nursing in PracticePhase III Trials Show Linagliptin Effectively Reduces Blood Glucose, With Good ... read more |